EDGAR Filing Documents for 0001193125-03-081884

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-03-081884

Filing Date

2003-11-14

Accepted

2003-11-14 15:29:26

Documents

Period of Report

2003-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	d10q.htm	10-Q	203459
3	MODIFICATION TO COMMERICAL PROMISSORY NOTE	dex1038.htm	EX-10.38	12527
4	LICENSE AGREEMENT	dex1039.htm	EX-10.39	148577
5	CERTIFICATION	dex311.htm	EX-31.1	9512
6	CERTIFICATION	dex312.htm	EX-31.2	9638
7	CERTIFICATION	dex321.htm	EX-32.1	2842
8	CERTIFICATION	dex322.htm	EX-32.2	2899
	Complete submission text file	0001193125-03-081884.txt		391740

Mailing Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615

Business Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615 9198621000

SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23265 | Film No.: 031004059
SIC: 2834 Pharmaceutical Preparations